Finch Therapeutics Group, Inc.
FNCH
$13.45
-$0.55-3.93%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.30% | 10.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.30% | 10.32% | |||
| Operating Income | -18.30% | -10.32% | |||
| Income Before Tax | -24.72% | -27.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.72% | -27.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.72% | -27.46% | |||
| EBIT | -18.30% | -10.32% | |||
| EBITDA | -18.43% | -10.44% | |||
| EPS Basic | -24.72% | -27.44% | |||
| Normalized Basic EPS | -25.82% | -14.74% | |||
| EPS Diluted | -24.72% | -27.44% | |||
| Normalized Diluted EPS | -25.82% | -14.74% | |||
| Average Basic Shares Outstanding | 0.00% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
